Comerica Securities,Inc. Gilead Sciences, Inc. Transaction History

Comerica Securities,Inc.

$1.2 Billion
Q3 2023

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$76.01 - $86.7 $173,302 - $197,676	-2,280 Reduced 39.91%	3,433 $264,000
Q1 2023 Apr 27, 2023	SELL	$77.31 - $88.08 $396,986 - $452,290	-5,135 Reduced 47.34%	5,713 $474,000
Q4 2022 Feb 10, 2023	BUY	$62.32 - $89.47 $211,077 - $303,034	3,387 Added 45.4%	10,848 $931,000
Q3 2022 Nov 07, 2022	BUY	$59.54 - $68.01 $88,357 - $100,926	1,484 Added 24.83%	7,461 $460,000
Q2 2022 Jul 19, 2022	BUY	$57.72 - $65.01 $55,584 - $62,604	963 Added 19.21%	5,977 $369,000
Q1 2022 Apr 28, 2022	BUY	$57.92 - $72.58 $34,404 - $43,112	594 Added 13.44%	5,014 $298,000
Q4 2021 Feb 10, 2022	SELL	$64.88 - $73.64 $118,665 - $134,687	-1,829 Reduced 29.27%	4,420 $321,000
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $4,196 - $4,527	62 Added 1.0%	6,249 $436,000
Q2 2021 Aug 11, 2021	SELL	$63.47 - $69.35 $98,949 - $108,116	-1,559 Reduced 20.13%	6,187 $426,000
Q1 2021 May 12, 2021	SELL	$60.0 - $68.46 $127,260 - $145,203	-2,121 Reduced 21.5%	7,746 $501,000
Q4 2020 Feb 09, 2021	SELL	$56.65 - $64.55 $159,922 - $182,224	-2,823 Reduced 22.25%	9,867 $575,000
Q3 2020 Nov 04, 2020	BUY	$62.1 - $78.08 $99,918 - $125,630	1,609 Added 14.52%	12,690 $802,000
Q2 2020 Jul 17, 2020	SELL	$72.34 - $84.0 $389,912 - $452,760	-5,390 Reduced 32.72%	11,081 $853,000
Q1 2020 Apr 16, 2020	SELL	$62.63 - $80.22 $14,592 - $18,691	-233 Reduced 1.39%	16,471 $1.23 Million
Q4 2019 Feb 11, 2020	BUY	$61.62 - $67.78 $33,028 - $36,330	536 Added 3.32%	16,704 $1.09 Million
Q3 2019 Oct 15, 2019	SELL	$62.51 - $69.0 $1.57 Million - $1.73 Million	-25,068 Reduced 60.79%	16,168 $1.03 Million
Q3 2019 Oct 15, 2019	BUY	$62.51 - $69.0 $2.1 Million - $2.32 Million	33,574 Added 438.19%	41,236 $2.58 Million
Q2 2019 Aug 09, 2019	SELL	$61.87 - $69.38 $1.82 Million - $2.04 Million	-29,435 Reduced 79.35%	7,662 $518,000
Q1 2019 May 07, 2019	BUY	$62.53 - $70.05 $2.32 Million - $2.6 Million	37,097 New	37,097 $2.41 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Securities,Inc., based on Form 13F filings with the SEC.

News

Stay updated on Comerica Securities,Inc. with notifications on news.

Account